Gutierrez-Hartmann A - Search Results

1

Ultrasound-mediated delivery of siESE complexed with microbubbles attenuates HER2+/- cell line proliferation and tumor growth in rodent models of breast cancer.

Song KH, Trudeau T, Kar A, Borden MA, Gutierrez-Hartmann A. Song KH, et al. Among authors: gutierrez hartmann a. Nanotheranostics. 2019 May 13;3(2):212-222. doi: 10.7150/ntno.31827. eCollection 2019. Nanotheranostics. 2019. PMID: 31183315 Free PMC article.

2

ESE-1 Knockdown Attenuates Growth in Trastuzumab-resistant HER2⁺ Breast Cancer Cells.

Kar A, Liu B, Gutierrez-Hartmann A. Kar A, et al. Among authors: gutierrez hartmann a. Anticancer Res. 2017 Dec;37(12):6583-6591. doi: 10.21873/anticanres.12115. Anticancer Res. 2017. PMID: 29187433 Free PMC article.

3

ETS transcription factor ESE-1/Elf3 is an independent prognostic factor of survival in HR⁺HER2⁺ breast cancer patients.

Kar A, Koto K, Walker D, Trudeau T, Edgerton S, Thor A, Gutierrez-Hartmann A. Kar A, et al. Among authors: gutierrez hartmann a. Breast Cancer Res Treat. 2020 Aug;182(3):601-612. doi: 10.1007/s10549-020-05734-y. Epub 2020 Jun 19. Breast Cancer Res Treat. 2020. PMID: 32562116

4

High Efficiency Molecular Delivery with Sequential Low-Energy Sonoporation Bursts.

Song KH, Fan AC, Brlansky JT, Trudeau T, Gutierrez-Hartmann A, Calvisi ML, Borden MA. Song KH, et al. Theranostics. 2015 Oct 18;5(12):1419-27. doi: 10.7150/thno.13033. eCollection 2015. Theranostics. 2015. PMID: 26681986 Free PMC article.

5

ESE-1/ELF3 mRNA expression associates with poor survival outcomes in HER2⁺ breast cancer patients and is critical for tumorigenesis in HER2⁺ breast cancer cells.

Kar A, Gutierrez-Hartmann A. Kar A, et al. Among authors: gutierrez hartmann a. Oncotarget. 2017 Jun 27;8(41):69622-69640. doi: 10.18632/oncotarget.18710. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050229 Free PMC article.

6

Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype.

Booth A, Trudeau T, Gomez C, Lucia MS, Gutierrez-Hartmann A. Booth A, et al. Mol Endocrinol. 2014 Dec;28(12):1999-2011. doi: 10.1210/me.2014-1168. Mol Endocrinol. 2014. PMID: 25361391 Free PMC article.

7

Pituitary somatolactotropes evade an oncogenic response to Ras.

Roof AK, Trudeau T, Gutierrez-Hartmann A. Roof AK, et al. Among authors: gutierrez hartmann a. Mol Cell Endocrinol. 2018 Nov 15;476:165-172. doi: 10.1016/j.mce.2018.05.006. Epub 2018 May 9. Mol Cell Endocrinol. 2018. PMID: 29753028 Free PMC article.

8

The Balance of PI3K and ERK Signaling Is Dysregulated in Prolactinoma and Modulated by Dopamine.

Roof AK, Jirawatnotai S, Trudeau T, Kuzyk C, Wierman ME, Kiyokawa H, Gutierrez-Hartmann A. Roof AK, et al. Among authors: gutierrez hartmann a. Endocrinology. 2018 Jun 1;159(6):2421-2434. doi: 10.1210/en.2017-03135. Endocrinology. 2018. PMID: 29726995 Free PMC article.

9

Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Kar A, Gutierrez-Hartmann A. Kar A, et al. Crit Rev Biochem Mol Biol. 2013 Nov-Dec;48(6):522-43. doi: 10.3109/10409238.2013.838202. Epub 2013 Sep 25. Crit Rev Biochem Mol Biol. 2013. PMID: 24066765 Free PMC article. Review.

10

Benign mammary epithelial cells enhance the transformed phenotype of human breast cancer cells.

Poczobutt JM, Tentler J, Lu X, Schedin PJ, Gutierrez-Hartmann A. Poczobutt JM, et al. BMC Cancer. 2010 Jul 16;10:373. doi: 10.1186/1471-2407-10-373. BMC Cancer. 2010. PMID: 20637104 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters